Navigation Links
Non-communicable diseases at the center of UN discussions
Date:9/23/2011

The European Chronic Disease Alliance (ECDA)1 welcomes the UN High Level Meeting on Non Communicable Diseases (NCDs) to address the world biggest killers. "It is a memorable day in the history of public health. Discussing non communicable diseases at the UN table gives a strong sense of the burden it represents to human kind and the recognition that NCDs is a challenge for all nations in the world2", declared Professor Michel Komajda, President of the European Society of Cardiology, an active member of the ECDA.

Indeed, non-communicable diseases a group of conditions that includes cardiovascular diseases, cancer, kidney disease, liver disease, diabetes mellitus, chronic respiratory disease and musculoskeletal conditions remain the leading cause of death in Europe, accounting for 86% of deaths and 77% of the disease burden in the WHO European Region.

Over the last year, the European Chronic Disease Alliance mobilised European and national leaders, calling for a strong final declaration on the fight of non communicable diseases.

The ECDA had high expectations, in particular on clear and ambitious targets that nations could adhere to. Unfortunately, the proposal to reduce non communicable disease by 25% by 2025 did not survive the negotiations.

Nor did the proposals on salt reduction or on the accountability of member states, that the ECDA strongly advocated for in Europe3

In addition, calls for enforceable targets to limit the harmful consumption of alcohol were also ignored".

"What gets measured gets done", said Susanne Lgstrup, quoting the Director-General of WHO from the European Heart Network, one of the founding members of the ECDA. "Failing to have measurable and timely targets in the final declaration is a bitter disappointment".

The ECDA will now look at how to implement the UN Political Declaration, in particular at EU level.

"We must emphasise the role of the scientist in measuring the success of the UN objectives. We have to work harder to collect data and improve monitoring and surveillance so that what gets done to reduce NCDs gets measured. We need to have the right methods, the right tools to do this, through academic science and methodology. Scientific and medical societies are best placed to do this and we must engage in this process", says Marc Decramer, President of the European Respiratory Society, an ECDA member.

A more ambitious approach was favoured by Members of the European Parliament last week, with the vote of a motion for a resolution4 that calls for the urgent adoption of NCDs prevention measures across Europe.

We will continue our efforts to promote a Europe less vulnerable to chronic diseases and to disseminate our policy recommendations, much of them only requiring simple and cheap changes with substantial impact on the diseases burden.


'/>"/>

Contact: Sophie O'Kelly
sokelly@escardio.org
33-049-294-8662
European Society of Cardiology
Source:Eurekalert

Related medicine news :

1. UN Member States jeopardize international progress on non-communicable disease epidemic
2. Global fight against non-communicable diseases should take lessons from HIV-AIDS
3. U.N. Summit Seeks to Tame Non-Communicable Diseases
4. Global Toll of Non-Communicable Diseases -- $47 Trillion by 2030
5. Hypnosis can relieve symptoms in children with respiratory diseases
6. 29 Clear Channel stations Nationwide Raise Nearly $2.8 Million to Help Save the Lives of Kids Fighting Cancer and Other Deadly Diseases
7. SRI International Expands Neurosciences Research with New Neurodegenerative Diseases Research Program
8. NHLBI, CDC launch surveillance and research program for inherited blood diseases
9. reco jeans Supports Children With Rare Diseases
10. HIV and noncommunicable diseases hinder the progress of poor countries Millennium Development Goals
11. Hard to Treat Diseases (HTDS) Releases 09 Financials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... 2016 , ... Stephanie Hebert Insurance Agency, serving families of ... charity campaign. As part of their ongoing community involvement program, funds are now ... children deserve a voice, and in the spirit of neighbors helping neighbors in ...
(Date:2/8/2016)... , ... February 08, 2016 , ... A man who has struggled to quit smoking, ... Laser Therapy , was determined to find solutions to his problems – and he did. ... Digest is ready to introduce his breakthrough inventions to the world and better people's ...
(Date:2/8/2016)... York, NY (PRWEB) , ... February 08, 2016 , ... ... are too much to handle, you are not alone. According to the Center for ... include heart disease, stroke, type 2 diabetes and certain types of cancer, some of ...
(Date:2/8/2016)... Hilton Head Island, SC (PRWEB) , ... February 08, 2016 , ... ... Head and surrounding areas with a vital new community enrichment program, has teamed up ... to local women and children suffering from intimate abuse. To support all those victimized ...
(Date:2/8/2016)... ... February 08, 2016 , ... Local ... the greater Venice, FL area, has initiated a fundraiser for a two year ... just four days after Christmas. To support this beautiful child who is facing ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... Cardiovascular Surgery Devices - Medical Devices Pipeline Assessment, ... report, "Cardiovascular Surgery Devices - Medical Devices Pipeline ... Devices currently in pipeline stage. ... comprehensive information on the pipeline products with comparative ... development. The report reviews major players involved in ...
(Date:2/8/2016)... 2016  Labvantage Lx, a newcomer to the ... sexual enhancement product, EnduramenT. Setting a new standard ... a patented biomedical breakthrough molecule that promotes the ... responsible for many biological functions including erectile function. ... Forgoing the use of prescription medications, scientists working ...
(Date:2/8/2016)... TOKYO and FAIRFIELD, N.J. ... (Otsuka) and Medimetriks Pharmaceuticals, Inc. (Medimetriks) today announced that ... exclusive development and commercialization rights for OPA-15406 in the ... agreement also provides manufacturing rights.  OPA-15406 is a topical, ... for atopic dermatitis. --> ...
Breaking Medicine Technology: